Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma?

Cytoreductive nephrectomy has been an integral part of management in metastatic renal cell carcinoma for patients with good performance status, based on the benefit shown by prospective trials in the interferon era and retrospective trials in the targeted therapies era. Clinical Trial to Assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Renner, Alex, Samtani, Suraj, Marín, Arnaldo, Burotto, Mauricio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Codon Publications 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403966/
https://www.ncbi.nlm.nih.gov/pubmed/30881867
http://dx.doi.org/10.15586/jkcvhl.2019.114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403966/
https://www.ncbi.nlm.nih.gov/pubmed/30881867
http://dx.doi.org/10.15586/jkcvhl.2019.114

Ejemplares similares